Defining preclinical stages of Crohn’s disease by faecal calprotectin and other risk factors: response to letter

  • Dan Turner*
  • , Sarah Kenigsberg
  • , Gili Focht
  • , Kenneth Croitoru
  • *Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article numbergutjnl-2026-338188
JournalGut
DOIs
StateAccepted/In press - 2026

Keywords

  • BIOMARKERS
  • CROHN'S DISEASE

Cite this